FIELD: organic chemistry, pharmacy.
SUBSTANCE: invention relates to 1,4- and 1,3-disubstituted piperidines that elicit the activity stimulating secretion of the hypophysis growth hormone in mammal. These compounds can be used in medicine.
EFFECT: valuable medicinal properties of compounds and pharmaceutical compositions.
4 cl, 1 tbl, 26 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2-AMINO-N-{(1R)-2-[(3R)-3-BENZYL-3-(N,N',N'-TRIMETHYLHYDRAZINOCARBONYL)PIPERIDINE-1-YL]-1-(1H-INDOL-3-YLMETHYL)-2-OXOETHYL}-2-METHYLPROPIONAMIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR STIMULATION OF GROWTH HORMONE RELEASE FROM MAMMAL HYPOPHYSIS | 2000 |
|
RU2272034C2 |
| COMPOUNDS AND PHARMACEUTICAL COMPOSITION POSSESSING PROPERTY FOR GROWTH HORMONE RELEASING, METHOD FOR STIMULATION OF SECRETION OF GROWTH HORMONE FROM MAMMAL HYPOPHYSIS | 1999 |
|
RU2298547C2 |
| DERIVATIVES OF INDOLE ORDER AS p38 KINASE INHIBITORS | 2000 |
|
RU2278115C2 |
| ANTAGONISTS OF PEPTIDE RECEPTOR FIXED WITH CALCITONIN GENE | 2003 |
|
RU2341526C2 |
| PYRIMIDINE DERIVATIVES WITH ANTAGONIST PROPERTIES TOWARDS CRTH2(VERSIONS) | 2004 |
|
RU2361865C2 |
| SUBSTITUTED DIKETOPIPERAZINES AS OXYTOCIN ANTAGONISTS | 2002 |
|
RU2303032C2 |
| TRICYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND USING THEM FOR TREATING IMMUNOLOGICAL AND ONCOLOGICAL COMPOUNDS | 2009 |
|
RU2545023C9 |
| INHIBITORS OF MENIN-MLL INTERACTION | 2017 |
|
RU2829484C2 |
| BORONIC ACID DERIVATIVES | 2015 |
|
RU2717558C2 |
| SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINEAMIDES AND THEIR DERIVATIVES, METHODS OF TREATMENT OF PATIENTS AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2143424C1 |
